Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation.
- 1 November 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 65 (5) , 1324-1329
- https://doi.org/10.1161/01.res.65.5.1324
Abstract
Numerous studies have shown that administration of atrial natriuretic factor (ANF) increases urinary sodium excretion and urine flow, decreases blood pressure, and inhibits renin and aldosterone release. However, the role of endogenous ANF in the regulation of renal sodium excretion, blood pressure, plasma renin activity, and aldosterone level remains to be elucidated. To examine this issue, endogenous ANF was blocked by administering rat ANF-(99-126) specific antiserum (Ab) to anesthetized rats (n = 7). Control animals received either no injection (time controls, n = 10) or preimmune serum (n = 8). Blockade of endogenous ANF caused a 28 +/- 0.09%, 47 +/- 0.08%, and 51 +/- 0.08% fall in sodium excretion at 15, 30, and 45 minutes after Ab injection (p less than 0.05, p less than 0.01, p less than 0.01, respectively). Urine flow fell 35 +/- 7% at 45 minutes after ANF inhibition (p less than 0.05). Plasma ANF levels were suppressed to undetectable levels. However, there were no changes in blood pressure throughout the experiment nor plasma renin concentration when measured at 45 minutes after Ab injection. Interestingly, plasma aldosterone concentration increased significantly (by approximately 50%, p less than 0.025), in response to Ab. Completeness of blockade was demonstrated by the absence of sodium excretion response to exogenous ANF (500 ng). In either the time control or the preimmune serum group, urinary excretion, blood pressure, plasma ANF, plasma renin concentration, and plasma aldosterone concentration were unchanged throughout the experiment. In contrast to the Ab group, a challenge with exogenous ANF (500 ng) increased sodium excretion by 2.17 mueq/min in the preimmune serum group.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 19 references indexed in Scilit:
- Plasma atrial natriuretic peptide in DOCA‐NaCl‐treated ratsActa Physiologica Scandinavica, 1987
- Effects of Atrial Appendectomy on Circulating Atrial Natriuretic Factor during Volume Expansion in the RatExperimental Biology and Medicine, 1986
- The renal action of atrial natriuretic peptide during control of glomerular filtrationKidney International, 1986
- Role of Atrial Natriuretic Factor in Renin Release*Endocrinology, 1986
- Acute volume expansion as a physiological stimulus for the release of atrial natriuretic peptides in the ratLife Sciences, 1986
- SYNTHETIC RAT ATRIAL NATRIURETIC FACTOR INHIBITSIN VITROANDIN VIVORENIN SECRETION IN RATSEndocrinology, 1985
- PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERSThe Lancet, 1985
- Changes of regional blood flow induced by atrial natriuretic factor (ANF) in conscious ratsLife Sciences, 1985
- RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERSThe Lancet, 1985
- Natriuretic effect of atrial extract on isolated perfused rat kidneyCanadian Journal of Physiology and Pharmacology, 1983